Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Towards a rational approach to vaccine development.

Leclerc C.

Hum Vaccin. 2010 Apr;6(4):292-6. Epub 2010 Apr 17. No abstract available.

PMID:
20372073
2.

How much help does a vaccine-induced T-cell response need?

Weber JS, Mulé JJ.

J Clin Invest. 2001 Mar;107(5):553-4. No abstract available.

3.

DC-based cancer vaccines: lessons from clinical trials.

Brody JD, Engleman EG.

Cytotherapy. 2004;6(2):122-7. Review. No abstract available.

PMID:
15203988
4.

DNA vaccines for cancer too.

Yu M, Finn OJ.

Cancer Immunol Immunother. 2006 Feb;55(2):119-30. Epub 2005 Jul 20. Review. No abstract available.

PMID:
16032397
5.

Formulation and characterization of a ten-peptide single-vial vaccine, EP-2101, designed to induce cytotoxic T-lymphocyte responses for cancer immunotherapy.

Beebe M, Qin M, Moi M, Wu S, Heiati H, Walker L, Newman M, Fikes J, Ishioka GY.

Hum Vaccin. 2008 May-Jun;4(3):210-8. Epub 2010 May 11.

PMID:
18382135
6.

Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations.

Hamdy S, Haddadi A, Hung RW, Lavasanifar A.

Adv Drug Deliv Rev. 2011 Sep 10;63(10-11):943-55. doi: 10.1016/j.addr.2011.05.021. Epub 2011 Jun 6. Review.

PMID:
21679733
7.

Bacteriology: a caring culture.

DeWeerdt S.

Nature. 2013 Dec 19;504(7480):S4-5. doi: 10.1038/504S4a. No abstract available.

PMID:
24352362
8.

The molecular basis of cancer immunotherapy by cytotoxic T lymphocytes.

Lindauer M, Stanislawski T, Häussler A, Antunes E, Cellary A, Huber C, Theobald M.

J Mol Med (Berl). 1998 Jan;76(1):32-47. Review.

PMID:
9462866
9.

Potential approaches for more successful dendritic cell-based immunotherapy.

Chiang CL, Balint K, Coukos G, Kandalaft LE.

Expert Opin Biol Ther. 2015 Apr;15(4):569-82. doi: 10.1517/14712598.2015.1000298. Epub 2015 Jan 2. Review.

PMID:
25553913
10.

Dendritic cell vaccine and cancer treatment: new patents.

Aleixo AA, Michelin MA, Murta EF.

Recent Pat Endocr Metab Immune Drug Discov. 2014 Jan;8(1):26-9.

PMID:
24397783
11.

Dendritic cell-based vaccines: from mouse models to clinical cancer immunotherapy.

Schreurs MW, Eggert AA, Punt CJ, Figdor CG, Adema GJ.

Crit Rev Oncog. 2000;11(1):1-17. Review.

PMID:
10795625
12.

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy.

Fong L, Hou Y, Rivas A, Benike C, Yuen A, Fisher GA, Davis MM, Engleman EG.

Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8809-14. Epub 2001 Jun 26.

13.

Idiotype vaccination strategies in myeloma: how to overcome a dysfunctional immune system.

Rhee Fv.

Clin Cancer Res. 2007 Mar 1;13(5):1353-5. Review. No abstract available.

14.

Dendritic cells in cancer vaccines.

Brossart P, Wirths S, Brugger W, Kanz L.

Exp Hematol. 2001 Nov;29(11):1247-55. Review.

PMID:
11698120
15.

CpG-conjugated apoptotic tumor cells elicit potent tumor-specific immunity.

Shirota H, Klinman DM.

Cancer Immunol Immunother. 2011 May;60(5):659-69. doi: 10.1007/s00262-011-0973-y. Epub 2011 Feb 4.

PMID:
21318638
16.

Tocotrienols are good adjuvants for developing cancer vaccines.

Hafid SR, Radhakrishnan AK, Nesaretnam K.

BMC Cancer. 2010 Jan 6;10:5. doi: 10.1186/1471-2407-10-5.

17.

The use of dendritic cells in cancer immunotherapy.

Schuler G, Schuler-Thurner B, Steinman RM.

Curr Opin Immunol. 2003 Apr;15(2):138-47. Review.

PMID:
12633662
18.

[Initial research of the effect and mechanism of cytotoxic T lymphocyte (lymphocyte) primed by dendritic cell as hepatocellular carcinoma vaccine].

Guo JW, Qin LW, Cai MY, Guo YB, Lu TD, Yu L.

Zhonghua Gan Zang Bing Za Zhi. 2003 Jul;11(7):414, 417. Chinese. No abstract available.

PMID:
12890344
19.

Immunotherapy of hematological malignancies using dendritic cells.

Van de Velde AL, Berneman ZN, Van Tendeloo VF.

Bull Cancer. 2008 Mar;95(3):320-6. doi: 10.1684/bdc.2008.0602. Review.

20.

Gold nanoparticles displaying tumor-associated self-antigens as a potential vaccine for cancer immunotherapy.

Ahn S, Lee IH, Kang S, Kim D, Choi M, Saw PE, Shin EC, Jon S.

Adv Healthc Mater. 2014 Aug;3(8):1194-9. doi: 10.1002/adhm.201300597. Epub 2014 Mar 20.

PMID:
24652754

Supplemental Content

Support Center